BLRX Stock Analysis: Buy, Sell, or Hold?
BLRX - BioLineRX Ltd
$3.12
-0.25 (-7.57%)
▼
5d:
+3.15%
30d:
-1.42%
90d:
+30.88%
BUY
MODERATE Confidence
Analysis Updated: Jun 25, 2026 12:00 AM ET
Earnings: Aug 13, 2026
Get Alerted When BLRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: BLRX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: BLRX is currently trading at $3.12, which is considered fair relative to its 30-day fair value range of $2.96 to $3.46.
Technical Outlook: Technically, BLRX is in a uptrend. Immediate support is located at $2.98, while resistance sits at $3.60. Short-term momentum is weak, with the stock down 7.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+461.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLRX is in a uptrend. Immediate support is located at $2.98, while resistance sits at $3.60. Short-term momentum is weak, with the stock down 7.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $17.50 (+461.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.96 -
$3.46
Company Quality Score
51/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
69.5%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-7.6%)
- BULLISH: Trading 461.8% below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$2.96 -
$3.46
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.98
Resistance Level
$3.60
Current Trend
Uptrend
Technical data as of
Jun 25, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-4.87
Wall Street Target
$17.50
(+461.8%)
Revenue Growth (YoY)
87.1%
Share & Embed Analysis
Last updated: June 26, 2026 6:27 AM ET
Data refreshes hourly during market hours. Next update: 7:27 AM
Data refreshes hourly during market hours. Next update: 7:27 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NTLA
Intellia Therapeutics Inc |
STRONG BUY
29 analysts |
$27 | 56 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$412 | 54 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 58 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
